Open a bounty challenge Fund this gap and accept submissions. SPEC-033.
Composite
Novelty
Mechanistic
Druggability
Priority
74%
Importance
72%
Tractability
85%
Market price
50%

Description

The study only tested paclitaxel, leaving unknown whether CX43-STAT1 mediated protection is drug-specific or represents a general resistance mechanism. This knowledge gap affects the broader applicability of targeting this pathway for brain metastasis treatment.

Gap type: open_question Source paper: Astrocytes Protect Brain Metastatic Breast Cancer Cells From Chemotherapy Through CX43 Dependent STAT1 Signaling in Co-Culture Spheroids. (2026, Biotechnol Bioeng, PMID:41486609)